Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
Titel:
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
Auteur:
Kerns, Sarah L. Amidon Morlang, Ashley Lee, Sharon M. Peterson, Derick R. Marples, Brian Zhang, Hong Bylund, Kevin Rosenzweig, Doug Hall, William De Ruyck, Kim Rosenstein, Barry S. Stock, Richard G. Gómez-Caamaño, Antonio Vega, Ana Sosa-Fajardo, Paloma Taboada-Valladares, Begoña Aguado-Barrera, Miguel E. Parker, Chris Veldeman, Liv Fonteyne, Valérie Bultijnck, Renée Talbot, Christopher J. Symonds, R. Paul Johnson, Kerstie Rattay, Tim Webb, Adam Lambrecht, Maarten de Ruysscher, Dirk Vanneste, Ben Choudhury, Ananya Elliott, Rebecca M. Sperk, Elena Herskind, Carsten Veldwijk, Marlon R. Rancati, Tiziana Avuzzi, Barbara Valdagni, Riccardo Azria, David Farcy Jacquet, Marie-Pierre Chang-Claude, Jenny Seibold, Petra West, Catharine Janelsins, Michelle Chen, Yuhchyau Messing, Edward Morrow, Gary